Dyne spikes as late-stage trial for Duchenne therapy gets underway
Dyne Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $18.63
+3.4% in 3d after detection
Post-detection moves
1h
—
1d
-1.1%
3d
+3.4%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS